• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种新开发的微量稀释试验——肉汤MIC NTM用于测定非结核分枝杆菌抗菌药物最低抑菌浓度的多中心评估]

[Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].

作者信息

Yamane Nobuhisa, Onaga Sayuri, Saitoh Hiroshi, Toyoshima Shunkoh, Shimojima Masahiro, Kawahara Shin, Takashima Tetsuya, Yamashita Tomonari

机构信息

Department of Laboratory Medicine, Faculty of Medicine, University of the Ryukyus, Nakagami-gun, Okinawa-pref. 903-0215.

出版信息

Rinsho Byori. 2002 Apr;50(4):381-91.

PMID:12014018
Abstract

We developed a new broth microdilution susceptibility test for nontuberculous mycobacteria to determine minimum inhibitory concentrations(MICs). The test method utilized air-dried microplates containing serially diluted antimicrobial agents and the modified Middlebrook 7H9 broth. The nine agents tested were rifampicin, isoniazid, ethambutol, streptomycin, kanamycin, levofloxacin, clarithromycin, ethionamide and amikacin. The test plates were reconstituted by inoculation of 0.1 ml of cell suspensions prepared in distilled water by a 1:100 dilution of the 0.5 McFarland suspension. After inoculation, the isolates resulted in incubation at 36 degrees C with clarithromycin at pH 7.4, and with the remaining agents at pH 6.6. The growth endpoints were visually read after 7-day and 10-day incubations for slowly growing nontuberculous mycobacteria, and after 3-day and 5-day incubations for rapidly growing mycobacteria, respectively. The reproducibility was evaluated with the five ATCC reference strains of nontuberculous mycobacteria. Of the 1,287 repeated tests of the four ATCC slowly growing strains(M. avium, M. intracellulare, M. kansasii and M. gordonae), 1,200(93.2%) of the MICs read after 7-day incubation fell within 3 log 2 dilutions. Also, a strain of rapidly growing mycobacteria, M. fortuitum, was repeatedly tested, and the reproducibility was estimated to be 93.3% after 3-day incubation. A total of 728 clinical isolates of nontuberculous mycobacteria comprising 14 species were tested against nine agents. The MICs against nontuberculous mycobacteria distributed in a wide range, and the activities of rifampicin, levofloxacin, clarithromycin were more potent. These results demonstrate this newly developed test method to be a practical, rapid, quantitative means to determine MICs for nontuberculous mycobacteria in clinical laboratories.

摘要

我们开发了一种用于非结核分枝杆菌的新型肉汤微量稀释药敏试验,以确定最低抑菌浓度(MICs)。该试验方法使用含有系列稀释抗菌剂的空气干燥微孔板和改良的Middlebrook 7H9肉汤。所测试的九种药物为利福平、异烟肼、乙胺丁醇、链霉素、卡那霉素、左氧氟沙星、克拉霉素、乙硫异烟胺和阿米卡星。通过接种0.1 ml由0.5麦氏浊度标准液按1:100稀释于蒸馏水中制备的细胞悬液来重构试验平板。接种后,对于缓慢生长的非结核分枝杆菌,在36℃、pH 7.4条件下用克拉霉素培养,对于其余药物在pH 6.6条件下培养;对于快速生长的分枝杆菌,分别在3天和5天培养后观察生长终点。用五株非结核分枝杆菌的ATCC参考菌株评估重复性。在对四株ATCC缓慢生长菌株(鸟分枝杆菌、胞内分枝杆菌、堪萨斯分枝杆菌和戈登分枝杆菌)进行的1287次重复试验中,7天培养后读取的MICs中有1200次(93.2%)落在3个对数2稀释范围内。此外,对一株快速生长的分枝杆菌偶然分枝杆菌进行了重复试验,3天培养后的重复性估计为93.3%。对总共728株包含14个种的非结核分枝杆菌临床分离株进行了九种药物的测试。非结核分枝杆菌的MICs分布范围很广,利福平、左氧氟沙星、克拉霉素的活性更强。这些结果表明,这种新开发的试验方法是临床实验室中确定非结核分枝杆菌MICs的一种实用、快速、定量的手段。

相似文献

1
[Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].[一种新开发的微量稀释试验——肉汤MIC NTM用于测定非结核分枝杆菌抗菌药物最低抑菌浓度的多中心评估]
Rinsho Byori. 2002 Apr;50(4):381-91.
2
[Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].[评估一种新开发的肉汤微量稀释试验方法以确定分枝杆菌抗菌药物的最低抑菌浓度(MICs)]
Rinsho Byori. 1998 Jul;46(7):719-27.
3
[Multicenter evaluation of broth microdilution test, BrothMIC MTB, to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for Mycobacterium tuberculosis--evaluation of interlaboratory precision and interpretive compatibility with agar proportion method].[采用肉汤微量稀释法(BrothMIC MTB)测定结核分枝杆菌抗菌药物最低抑菌浓度(MIC)的多中心评估——实验室间精密度评估及与琼脂比例法的解释兼容性评估]
Rinsho Byori. 1999 Aug;47(8):754-66.
4
[Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].[使用肉汤微量法检测非结核分枝杆菌的抗分枝杆菌药敏性]
Kekkaku. 2006 Apr;81(4):329-35.
5
[Interpretive compatibility of antimycobacterial susceptibility for Mycobacterium tuberculosis determined by proportion test method on egg-based Ogawa media and broth microdilution test, BrothMIC MTB].[基于鸡蛋的小川培养基比例法与肉汤微量稀释法(BrothMIC MTB)测定结核分枝杆菌抗分枝杆菌药敏的解释兼容性]
Kekkaku. 2002 Feb;77(2):61-6.
6
Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.采用 slomyco 测试系统对缓慢生长非结核分枝杆菌进行药物敏感性测试。
PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018.
7
In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.从微生物角膜炎患者中分离出的快速生长非结核分枝杆菌的体外抗生素药敏性。
Curr Eye Res. 2010 Mar;35(3):225-9. doi: 10.3109/02713680903502258.
8
[A susceptibility study of Mycobacterium avium-intracellulare strains using the broth macrodilution method].[采用肉汤宏稀释法进行鸟分枝杆菌-胞内分枝杆菌菌株药敏试验]
Rev Cubana Med Trop. 1995;47(1):54-8.
9
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.氯法齐明的高效性及其与阿米卡星的协同作用对快速生长分枝杆菌。
Int J Antimicrob Agents. 2010 Apr;35(4):400-4. doi: 10.1016/j.ijantimicag.2009.12.008.
10
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.

引用本文的文献

1
Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pulmonary disease: a case report.免疫功能正常的患者无肺部疾病,由脊椎骨髓炎进展为脓胸的脓肿分枝杆菌复合群脓肿亚种感染:病例报告。
BMC Pulm Med. 2019 May 24;19(1):100. doi: 10.1186/s12890-019-0860-4.